Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.29M | -18.41M | -16.67M | -16.72M | -16.02M |
| Total Depreciation and Amortization | 726.80K | 682.40K | 638.10K | 606.20K | 573.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 372.80K | 177.70K | -511.50K | -496.90K | -147.60K |
| Change in Net Operating Assets | 3.01M | 331.90K | -17.40K | 1.03M | 979.80K |
| Cash from Operations | -17.18M | -17.22M | -16.56M | -15.58M | -14.61M |
| Capital Expenditure | -798.20K | -820.50K | -1.00M | -831.70K | -417.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.24M | -2.03M | 2.57M | 4.43M | 700.90K |
| Cash from Investing | -5.04M | -2.85M | 1.57M | 3.60M | 282.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 267.38M | 267.38M | 315.39M | 315.39M | 105.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.62M | -10.12M | 930.00K | 1.17M | 13.72M |
| Cash from Financing | 25.95M | 26.13M | 31.74M | 31.77M | 11.24M |
| Foreign Exchange rate Adjustments | 61.20K | 165.90K | 58.30K | 447.40K | 122.40K |
| Miscellaneous Cash Flow Adjustments | 19.10K | 19.00K | 19.00K | -100.00 | -100.00 |
| Net Change in Cash | 3.81M | 6.24M | 16.82M | 20.24M | -2.97M |